Skip to Main Content

Paper Details

Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice.
Sci Adv
4
2023
Author NameAffiliation
Ian A WilsonThe Scripps Research Institute
Ian A WilsonSkaggs Institute for Chemical Biology, The Scripps Research Institute
Lynda CoughlanUniversity of Maryland School of Medicine
Lynda CoughlanCenter for Vaccine Development and Global Health (CVD), University of Maryland School of Medicine
Peter PaleseIcahn School of Medicine at Mount Sinai
Peter PaleseIcahn School of Medicine at Mount Sinai
  • 1 - 6

Datasets